CAPR
Capricor Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Capricor Therapeutics has 4 disclosed suppliers and 7 disclosed customers in SEC filings.
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+57.96%
vs ±35.1% implied · ×1.65
shaded = implied · ▲▼ = realized
Capricor Therapeutics, Inc.
6.93
SentenceOn January 4, 2010, Capricor entered into an Exclusive License Agreement with CSMC (the "Original CSMC License Agreement"), for certain intellectual property related to its CDC technology.
CAPR 10-Kaccession 0001104659-26-029580
SentenceCapricor and JHU entered into an Exclusive License Agreement, effective June 22, 2006 (the "JHU License Agreement"), which provides for the grant of an exclusive, world-wide, royalty-bearing license by JHU to Capricor (with the right to sublicense) to develop and commercialize licensed products and licensed services under the licensed patent rights in all fields and a nonexclusive right to the know-how.
CAPR 10-Kaccession 0001104659-26-029580
SentenceOn March 7, 2022, Capricor entered into a non-exclusive cell line license agreement with Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, Inc., for the supply of certain cells which we are utilizing in connection with the development of our exosomes platform.
CAPR 10-Kaccession 0001104659-26-029580
SentenceCapricor has entered into exclusive license agreements for intellectual property rights related to certain cardiac-derived cells with Università Degli Studi Di Roma La Sapienza (the "University of Rome"), Johns Hopkins University and Cedars-Sinai Medical Center.
CAPR 10-Kaccession 0001104659-26-029580
SentenceOur collaborations and research around exosomes include the National Institutes of Health ("NIH"), the National Institute of Allergy and Infectious Diseases ("NIAID"), Johns Hopkins University ("JHU"), the Department of Defense ("DoD"), the U.S. Army Institute of Surgical Research ("USAISR"), and Cedars-Sinai Medical Center ("CSMC").
CAPR 10-Kaccession 0001104659-26-029580
SentenceOur collaborations and research around exosomes include the National Institutes of Health ("NIH"), the National Institute of Allergy and Infectious Diseases ("NIAID"), Johns Hopkins University ("JHU"), the Department of Defense ("DoD"), the U.S. Army Institute of Surgical Research ("USAISR"), and Cedars-Sinai Medical Center ("CSMC").
CAPR 10-Kaccession 0001104659-26-029580
SentenceOur collaborations and research around exosomes include the National Institutes of Health ("NIH"), the National Institute of Allergy and Infectious Diseases ("NIAID"), Johns Hopkins University ("JHU"), the Department of Defense ("DoD"), the U.S. Army Institute of Surgical Research ("USAISR"), and Cedars-Sinai Medical Center ("CSMC").
CAPR 10-Kaccession 0001104659-26-029580
SentenceAs part of Project NextGen, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, is conducting a Phase 1 clinical study with our StealthX™ vaccine which is currently ongoing.
CAPR 10-Kaccession 0001104659-26-029580
SentenceOur collaborations and research around exosomes include the National Institutes of Health ("NIH"), the National Institute of Allergy and Infectious Diseases ("NIAID"), Johns Hopkins University ("JHU"), the Department of Defense ("DoD"), the U.S. Army Institute of Surgical Research ("USAISR"), and Cedars-Sinai Medical Center ("CSMC").
CAPR 10-Kaccession 0001104659-26-029580
SentenceWe will depend on our exclusive distributor, Nippon Shinyaku, for the commercial sale of Deramiocel in Duchenne muscular dystrophy ("DMD") in the United States and Japan, if regulatory approval is obtained in those territories.
CAPR 10-Kaccession 0001104659-26-029580
SentenceOur collaborations and research around exosomes include the National Institutes of Health ("NIH"), the National Institute of Allergy and Infectious Diseases ("NIAID"), Johns Hopkins University ("JHU"), the Department of Defense ("DoD"), the U.S. Army Institute of Surgical Research ("USAISR"), and Cedars-Sinai Medical Center ("CSMC").
CAPR 10-Kaccession 0001104659-26-029580
Largest filed tie
—
Expected move
No implied move.